Exicure (NASDAQ:XCUR) Stock Price Up 4% – What’s Next?

Exicure, Inc. (NASDAQ:XCUR)’s stock price rose 4% during mid-day trading on Monday . The company traded as high as $5.06 and last traded at $4.72. Approximately 26,633 shares changed hands during mid-day trading, a decline of 36% from the average daily volume of 41,371 shares. The stock had previously closed at $4.54.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Exicure in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Exicure Stock Performance

The stock has a market cap of $29.83 million, a PE ratio of -1.22 and a beta of 3.76. The stock has a fifty day moving average price of $4.93 and a 200 day moving average price of $7.62.

Exicure (NASDAQ:XCUR) last announced its earnings results on Friday, August 8th. The company reported ($0.41) EPS for the quarter.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.